Cargando…

Neurocognition and Depressive Symptoms have Unique Pathways to Predicting Different Domains of Functioning in Major Depressive Disorder

BACKGROUND: Research has established the independent relationships between depressive symptoms to cognition and functioning in depression; however, little is known about the role of mediators in this relationship. We explored the role of neurocognitive abilities, depressive symptom severity, dysfunc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wood-Ross, Chelsea, Tran, Tanya, Milanovic, Melissa, Jokic, Ruzica, Milev, Roumen, Bowie, Christopher R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037745/ https://www.ncbi.nlm.nih.gov/pubmed/36411975 http://dx.doi.org/10.1177/07067437221133375

Ejemplares similares

Effects of quetiapine on sleep architecture in patients with unipolar or bipolar depression
por: Gedge, Laura, et al.
Publicado: (2010)

Repetitive transcranial magnetic stimulation for treatment of elderly patients with depression – an open label trial
por: Abraham, Gaby, et al.
Publicado: (2007)

Effects of Electroconvulsive Therapy and Repetitive Transcranial Magnetic Stimulation on Serum Brain-Derived Neurotrophic Factor Levels in Patients with Depression
por: Gedge, Laura, et al.
Publicado: (2012)

Sleep architecture and cognitive changes in olanzapine-treated patients with depression: A double blind randomized placebo controlled trial
por: Lazowski, Lauren K, et al.
Publicado: (2014)

A review of electroencephalographic changes in diabetes mellitus in relation to major depressive disorder
por: Baskaran, Anusha, et al.
Publicado: (2013)

Clinical and methodological considerations for psychological treatment of cognitive impairment in major depressive disorder
por: Douglas, Katie M., et al.
Publicado: (2020)

The effects of probiotics on depressive symptoms in humans: a systematic review
por: Wallace, Caroline J. K., et al.
Publicado: (2017)

Response of Depression to Botulinum Toxin Treatment: Agitation as a Predictor
por: Milev, Roumen
Publicado: (2015)

Erratum to: The effects of probiotics on depressive symptoms in humans: a systematic review
por: Wallace, Caroline J. K., et al.
Publicado: (2017)

The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depression and/or Generalized Anxiety Disorder: Protocol for a Phase 1, Open-Label Study
por: Chinna Meyyappan, Arthi, et al.
Publicado: (2020)

Microbial Ecosystem Therapeutic-2 Intervention in People With Major Depressive Disorder and Generalized Anxiety Disorder: Phase 1, Open-Label Study
por: Chinna Meyyappan, Arthi, et al.
Publicado: (2022)

Olfactory Functioning and Depression: A Systematic Review
por: Taalman, Hannah, et al.
Publicado: (2017)

Mechanisms Underlying Neurocognitive Dysfunctions in Recurrent Major Depression
por: Gałecki, Piotr, et al.
Publicado: (2015)

The Efficacy, Safety, and Tolerability of Probiotics on Depression: Clinical Results From an Open-Label Pilot Study
por: Wallace, Caroline J. K., et al.
Publicado: (2021)

Subjective experiences of neurocognitive functioning in young people with major depression
por: Morey-Nase, Catherine, et al.
Publicado: (2019)

Functional Recovery in Major Depressive Disorder: Providing Early Optimal Treatment for the Individual Patient
por: Oluboka, Oloruntoba J, et al.
Publicado: (2017)

Neurocognitive profile in major depressive disorders: relationship to symptom level and subjective memory complaints
por: Mohn, Christine, et al.
Publicado: (2016)

The Safety and Efficacy of Microbial Ecosystem Therapeutic-2 in People With Major Depression: Protocol for a Phase 2, Double-Blind, Placebo-Controlled Study
por: Chinna Meyyappan, Arthi, et al.
Publicado: (2021)

Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder
por: Miskowiak, Kamilla W, et al.
Publicado: (2010)

The role of major depression in neurocognitive functioning in patients with posttraumatic stress disorder
por: Nijdam, Mirjam J., et al.
Publicado: (2013)

Cognitive Impairment and Neurocognitive Profiles in Major Depression—A Clinical Perspective
por: Hammar, Åsa, et al.
Publicado: (2022)

Assessing Neurocognition (P300) and Correlating Them to Depression Rating Scales in Patients With Major Depressive Disorder
por: Wakode, Santosh, et al.
Publicado: (2022)

The impact of non-infection pandemic stress on depression and anxiety severity: Investigating mediation by intrusive and deliberate rumination
por: Squires, Scott D., et al.
Publicado: (2022)

Rasch analyses of the Quick Inventory of Depressive Symptomatology Self-Report in neurodegenerative and major depressive disorders
por: Vaccarino, Anthony L., et al.
Publicado: (2023)

Neurocognition Function of Patients With Bipolar Depression, Unipolar Depression, and Depression With Bipolarity
por: Lu, Zhe, et al.
Publicado: (2021)

Data and alternative models describing the associations among non-infection pandemic stress, event-related rumination, depression, and anxiety
por: Hu, Mianzhi, et al.
Publicado: (2022)

Accuracy of three depression screening scales to diagnose major depressive episodes in older adults without neurocognitive disorders
por: Costa, Mônica V., et al.
Publicado: (2016)

Neurocognitive Effects of Repetitive Transcranial Magnetic Stimulation in Adolescents with Major Depressive Disorder
por: Wall, Christopher A., et al.
Publicado: (2013)

Characterizing neurocognitive impairment in young people with major depression: state, trait, or scar?
por: Allott, Kelly, et al.
Publicado: (2016)

Does Napping Enhance the Consolidation of Clinically Relevant Information? A Comparison of Individuals with Low and Elevated Depressive Symptoms
por: Lo, Edwyn B L, et al.
Publicado: (2021)

Maintained Improvement of Neurocognitive Function in Major Depressive Disorders 6 Months after ECT
por: Mohn, Christine, et al.
Publicado: (2016)

An Update on Neurocognitive Impairment in Schizophrenia and Depression
por: Hugdahl, Kenneth, et al.
Publicado: (2010)

The THINC-it Tool for Cognitive Assessment and Measurement in Major Depressive Disorder: Sensitivity to Change
por: McIntyre, Roger S., et al.
Publicado: (2020)

Neurocognitive Performance in Depressed Patients with low-grade inflammation and somatic symptoms
por: Kaser, Muzaffer, et al.
Publicado: (2021)

Editorial: Neurocognitive disorders and depression—Complex interrelationships
por: Broczek, Katarzyna Milana, et al.
Publicado: (2023)

Using neurocognitive models to optimise the treatment of depression
por: Murphy, S.
Publicado: (2023)

Pathways from maternal depressive symptoms to adolescent depressive symptoms: the unique contribution of irritability symptoms
por: Whelan, Yvonne M., et al.
Publicado: (2015)

Accelerated brain aging in major depressive disorder and antidepressant treatment response: A CAN-BIND report
por: Ballester, Pedro L., et al.
Publicado: (2021)

A randomized, crossover comparison of ketamine and electroconvulsive therapy for treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocol
por: Phillips, Jennifer L., et al.
Publicado: (2020)

Association of neurocognitive function with psychiatric hospitalization and socio-demographic conditions in individuals with bipolar and major depressive disorders
por: Sankar, Anjali, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5aqrrk3kgjhj93fmlsascl7dc4